GAD2 and vitiligo: Autoimmune comorbidities are frequent in patients with GAD65-ab related neurological disorders, including autoimmune thyroid disease (30–48%), T1DM (11–30%), vitiligo (2–16%), and rheumatic disorders (6–7%) (10, 13–15).